The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2

The outbreak of the 2019 Novel Coronavirus (SARS-CoV-2) rapidly spread from Wuhan, China to more than 150 countries, areas, or territories, causing staggering numbers of infections and deaths. In this study, bioinformatics analyses were performed on 5,568 complete genomes of SARS-CoV-2 virus to predict the T cell and B cell immunogenic epitopes of all viral proteins, which formed a systematic immune vulnerability landscape of SARS-CoV-2. The immune vulnerability and genetic variation profiles of SARS-CoV were compared with those of SARS-CoV and MERS-CoV. In addition, a web portal was developed to broadly share the data and results as a resource for the research community. Using this resource, we showed that genetic variations in SARS-CoV-2 are associated with loss of B cell immunogenicity, an increase in CD4+ T cell immunogenicity, and a minimum loss in CD8+ T cell immunogenicity, indicating the existence of a curious correlation between SARS-CoV-2 genetic evolutions and the immunity pressure from the host. Overall, we present an immunological resource for SARS-CoV-2 that could promote both therapeutic/vaccine development and mechanistic research.

[1]  Y. Hu,et al.  [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[2]  R. Scheuermann,et al.  A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2 , 2020, Cell Host & Microbe.

[3]  Xiaoping Tang,et al.  Asymptomatic SARS-CoV-2 infected patients with persistent negative CT findings , 2020, European Journal of Radiology.

[4]  Jing Liu,et al.  Asymptomatic cases in a family cluster with SARS-CoV-2 infection , 2020, The Lancet Infectious Diseases.

[5]  B. Graham,et al.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.

[6]  P. Niu,et al.  Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China , 2020, Cell Host & Microbe.

[7]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[8]  S. Lindstrom,et al.  First Case of 2019 Novel Coronavirus in the United States , 2020, The New England journal of medicine.

[9]  E. Holmes,et al.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.

[10]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[11]  Ralph S. Baric,et al.  Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus , 2020, Journal of Virology.

[12]  Laurentiu M. Pop,et al.  Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes , 2020, Science Immunology.

[13]  Vassiliki A. Iconomidou,et al.  Linear B-cell epitope prediction: a performance review of currently available methods , 2019, bioRxiv.

[14]  Kylie M. Quinn,et al.  CD4+ T help promotes influenza virus-specific CD8+ T cell memory by limiting metabolic dysfunction , 2019, Proceedings of the National Academy of Sciences.

[15]  Siobain Duffy,et al.  Why are RNA virus mutation rates so damn high? , 2018, PLoS biology.

[16]  T. Yeh,et al.  Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate , 2018, Journal of Biomedical Science.

[17]  R. Xu,et al.  Incorporation of NS1 and prM/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein , 2018, npj Vaccines.

[18]  J. Greenbaum,et al.  Improved methods for predicting peptide binding affinity to MHC class II molecules , 2018, Immunology.

[19]  J. L. Sánchez-Trincado,et al.  Fundamentals and Methods for T- and B-Cell Epitope Prediction , 2017, Journal of immunology research.

[20]  M. Nielsen,et al.  NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data , 2017, The Journal of Immunology.

[21]  Bjoern Peters,et al.  BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes , 2017, Nucleic Acids Res..

[22]  Arnone Nithichanon,et al.  A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines , 2017, Scientific Reports.

[23]  D. Middleton,et al.  HLA-A, -B, -C, and -DRB1 genotyping and haplotype frequencies for a Hong Kong Chinese population of 7595 individuals. , 2016, Human immunology.

[24]  D. Falzarano,et al.  SARS and MERS: recent insights into emerging coronaviruses , 2016, Nature Reviews Microbiology.

[25]  Colin M. Diesh,et al.  JBrowse: a dynamic web platform for genome visualization and analysis , 2016, Genome Biology.

[26]  M. Nielsen,et al.  NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets , 2016, Genome Medicine.

[27]  A. D. De Groot,et al.  H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated tolerance , 2015, Human vaccines & immunotherapeutics.

[28]  S. Perlman,et al.  Coronaviruses: An Overview of Their Replication and Pathogenesis , 2015, Methods in molecular biology.

[29]  Sergio Rosales-Mendoza,et al.  An overview of bioinformatics tools for epitope prediction: Implications on vaccine development , 2015, J. Biomed. Informatics.

[30]  Andrew R. Jones,et al.  Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations , 2014, Nucleic Acids Res..

[31]  D. Hinton,et al.  Enhanced CD8 T-cell anti-viral function and clinical disease in B7-H1-deficient mice requires CD4 T cells during encephalomyelitis , 2012, Journal of Neuroinflammation.

[32]  R. Philip,et al.  MHC Class I-Presented T Cell Epitopes Identified by Immunoproteomics Analysis Are Targets for a Cross Reactive Influenza-Specific T Cell Response , 2012, PloS one.

[33]  A. McMichael,et al.  Revealing the role of CD4+ T cells in viral immunity , 2012, The Journal of experimental medicine.

[34]  A. Bertoletti,et al.  Understanding the T cell immune response in SARS coronavirus infection , 2012, Emerging Microbes & Infections.

[35]  C. Zhou,et al.  Immunization with high epitope density of M2e derived from 2009 pandemic H1N1 elicits protective immunity in mice. , 2012, Vaccine.

[36]  D. Hinton,et al.  CD4 T Cells Promote CD8 T Cell Immunity at the Priming and Effector Site during Viral Encephalitis , 2011, Journal of Virology.

[37]  Christopher D. Paddock,et al.  Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4+ T Cells Are Important in Control of SARS-CoV Infection , 2009, Journal of Virology.

[38]  T. Randall,et al.  A Novel Role for Non-Neutralizing Antibodies against Nucleoprotein in Facilitating Resistance to Influenza Virus1 , 2008, The Journal of Immunology.

[39]  Morten Nielsen,et al.  Improved method for predicting linear B-cell epitopes , 2006, Immunome research.

[40]  A. Carattoli,et al.  Generation of human antibody fragments recognizing distinct epitopes of the nucleocapsid (N) SARS-CoV protein using a phage display approach , 2005, BMC infectious diseases.

[41]  Robert C. Edgar,et al.  MUSCLE: a multiple sequence alignment method with reduced time and space complexity , 2004, BMC Bioinformatics.

[42]  Robert C. Edgar,et al.  MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.

[43]  John L. Sullivan,et al.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.

[44]  I. Longden,et al.  EMBOSS: the European Molecular Biology Open Software Suite. , 2000, Trends in genetics : TIG.

[45]  E. Pfefferkorn,et al.  Arabinosyl nucleosides inhibit Toxoplasma gondii and allow the selection of resistant mutants. , 1976, The Journal of parasitology.

[46]  R. Baric,et al.  Receptor recognition by novel coronavirus from Wuhan: 2 An analysis based on decade-long structural studies of SARS 3 , 2020 .

[47]  C. Bailey-Kellogg,et al.  HCV epitope, homologous to multiple human protein sequences, induces a regulatory T cell response in infected patients. , 2015, Journal of hepatology.